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Recent serological analyses suggest that the antigen-binding molecule of certain T 
cells carries determinants that were originally defined on the variable region 0dH)1 of 
the  immunoglobulin  heavy  chain.  These  include  idiotypic  markers  linked  to  the 
immunoglobulin heavy chain gene cluster (Igh-1)  (1, 2)  and the framework determi- 
nants  of V~  (3-5),  In  addition,  genetic  evidence showed  that  the  expression  of a 
characteristic  fine  specificity  of hapten  recognition  by  T  cells  maps  to  the  Igh-1 
linkage  group  (4,  6).  In  accord,  recent  studies  have  reported  that  antigen-specific 
factors share idiotypic (7-10)  and VH (5,  1 1,  12)  determinants with antibodies. The 
constant region that is presumed to exist on the T  cell antigen-receptor and antigen- 
specific factors, however,  has been defined only negatively, in  that  Igh-1  constant- 
region determinants were not demonstrable (9-13). 
Based on the partial relationship documented between the antigen receptors used 
by B  and T  cells, Owen  et al.  (14,  15)  postulated  that  genes encoded  the constant 
region of the T  cell antigen receptor (IgT-C) may be located on chromosome 12, in 
close  proximity  to  VH  genes.  Successful  production  of antiserum  and  monoclonal 
antibodies specific for T  cell alloantigens was achieved by immunizing BALB/c mice 
with activated T  cells from the Igh allotype congenic mouse, C.AL-20 (14-18). Three 
T  cell markers that are linked to Igh-1, but are separable by genetic recombination, 
have been  identified  by monoclonal  antibodies.  The alloantigens  Tthy  a  (17),  Tsu  a 
(14,  15), and Tind  a (16) are expressed preferentially on thymocytes, peripheral Lyt-2  + 
and  Lyt-1  + T  cells, respectively, of mice possessing Igh  a and Igh  e allotypes.  In vivo 
pretreatment  of these mice with anti-Tsu  a elicits suppression  (15),  while anti-Tind a 
causes  either  suppression  or  enhancement  (16)  of a  primary  antibody  response. 
However, direct evidence that these alloantigens exist on an antigen-binding, biolog- 
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ically functional molecule produced by T  cells is lacking. 
Previous  publications  from  this  laboratory  reported  the  derivation  of a  T  cell 
hybridoma made by fusion of antigen-binding T  cells ofA/J  (H-2  a, Igh-l*) mice with 
the thymoma BW5147 (12,  19).  The cell line, designated FL10, can directly bind the 
antigen,  KLH, and  bears  on its surface a  structure  to which antibodies  against  the 
framework  of immunoglobulin  VH  cross-react  (12).  In  addition,  FL10  expresses  a 
unique I region-associated  (Ia) antigen and produces a characteristic antigen-specific, 
augmenting factor (TaF) that enhances the in vitro secondary response. TaF has been 
shown not to be helper T  cell replacing, but acts on other T  cells to induce augmention 
of the  antibody  response  (13).  The  specificity  of the  TaF  is  twofold in  that  it  can 
specifically bind to KLH and that augmentation is induced only when the responding 
cells  are  stimulated  by  haptenated  KLH.  This  T  cell  hybridoma  provided  the 
opportunity to utilize monoclonal anti-Tsu a and anti-Tind a antibodies  to determine 
directly whether TaF bears those well-defined allotypic determinants linked to Igh-1. 
In addition,  the existence of monoclonal antibodies specific for I region products on 
T  cells enabled us to study the relationship between Ia and IgT-C region determinants 
coexpressed on a  functional T  cell hybridoma. Evidence in support of the presence of 
IgT-C determinants  on a  molecule separate  from that  bearing  T  cell  Ia antigen  is 
presented in this communication. 
Materials  and Methods 
Mice.  A/J (H-2  a, Igh-l~), C3H  (H-2  k, Igh-lJ), C57BL/6 (H-2  b, Igh-lb), and B10.A (H-2  a, 
Igh-1  a)  were purchased from Ohmura Experimental  Animal Company (Kanagawa, Japan). 
d  d  C.AL-20  (H-2 ,  Igh-1 )  mice,  originally developed  by Dr.  Michael  Potter  at  the  National 
Institutes of Health, were propagated at the animal facilities  of both the University of Tokyo 
and Tufts University School of Medicine• C.AL-20 mice are congenic to BALB/c except for an 
undetermined number of genes linked to the Igh- 1 locus. BALB/cAnN animals were purchased 
from Charles River Breeding Laboratories, Inc., Wilmington, MA. 
Antigens.  Keyhole limpet  hemoeyanin  (KLH)  was  purchased  from Calbiochem-Behring 
Corp., American Hoeehst Corp., San Diego, CA. The dinitrophenylated (DNP) conjugate was 
prepared  by reaction  with  dinitrobenzene  sulfonate  under  alkaline  conditions.  The  molar 
substitution ratio was DNP61s-KLH (per 8 ×  106 D KLH). Bordetella  pertussis vaccine (PV) was 
purchased from Chiba Serum Institute, Chiba, Japan. 
Antisera.  The production and T  cell specificity of anti-Tsu a antiserum has been described 
previously (14,  15). Briefly, BALB/cAnN females were immunized with concanavalin A (Con 
A)-stimulated lymphoblasts generated in vitro from normal C.AL-20 spleen cells.  Polyvalent 
anti-mouse immunoglobulin antisera were obtained from rabbits and goats immunized with 
the 3,-globulin  fraction precipitated  from normal mouse serum with ammonium sulfate and 
then emulsified in complete Freund's adjuvant. 
Monoclonal Antibodies.  Hybridomas that were produced by fusion of BALB/e anti-C.AL-20 
splenocytes with the BALB/c myeloma, P.3U 1 and which make monoclonal antibodies specific 
for T cell alloantigens linked to the murine Igh-1 locus were described previously (16-18). The 
characterization and antigen assignment of monoclonal anti-Tsu a (clone 13IIIB4, IgG1 isotype), 
monoclonal anti-Tind  a (clone 9IIIA2, IgG1 isotype), and monoclonal anti-Tthy  d (clone 17IIC6, 
IgM isotype) have been reported.  A monoclonal antibody (14P)  against an I region-encoded 
determinant expressed on a mature subset of T  cells was reported previously (19). Clone 14P 
resulted from fusion ofA.TH anti-A.TL spleen cells with the BALB/c plasmacytoma, P3-X63- 
Ag-8-653.  The  I  region-controlled determinant  recognized by  14P  was mapped  to the  I-A 
subregion. 
T  Cell Hybridomas.  The T  cell  hybridoma, FL10, was made by fusion of KLH-binding T 
cells of A/J mice with the AKR thymoma, BW5147 as previously described (12). FL 10 expresses 
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secondary antibody response to DNP-KLH. An I-jk-positive T  cell hybridoma (7C3-13) with 
specificity for the hapten 4-hydroxy-3-nitrophenylacetyl  (NP) was established by fusion of NP- 
binding T cells from B10.BR mice with BW5147. Clone 7C3-13 was selected for by testing the 
expression of I-J  k and NP-specific suppressive activity, as will be described elsewhere  (Suzuki et 
al., submitted for publication). 
Typing of T  Cell Hybridomas by Immunofluorescence.  The T  cell hybridomas (5  ×  105) were 
incubated for  1 h  at 4°C in 50/~1 of Dulbecco's modified Eagle's medium containing 0.2% 
bovine serum albumin, 0.04 M NaNn, and conventional antiserum or monoclonal antibody in 
ascites  form. Cells were washed three times and then stained with fluorescein-conjugated  goat 
anti-mouse immunoglobulin for  1 h  at 4°C. After washing three more times, the cells were 
examined under a Vanox fluorescence microscope (Olympus, Tokyo, Japan). 
Preparation of Monoclonal KLH-specific TaF.  The preparation of cell-free extracts containing 
functional T  cell  factors  has  been described elsewhere  (20).  Briefly,  monoelonal TaF was 
prepared  by  disruption of  FL10  hybridoma cells  by  freezing  and  thawing,  followed  by 
ultracentrifugation of the extract at 30,000 g for 1 h at 4°C. The extract was then frozen and 
maintained at -80°C until further use. 
Adsorption and Elution of TaF with Immunoadsorbents.  For the preparation of each immunoad- 
sorbent column, 1 g of Sepharose 4B (Pharmacia Fine Chemicals) was coupled according to the 
method ofAxen et al. (21) with 10 mg of KLH or the ~,-globulin fraction of antiserum or ascites 
containing the IgGz  myeloma, MOPC-31, or hybridoma antibody. The immunoadsorbents 
were packed in 5-ml syringes. The cell-free extract of FL10 equivalent to 107 cells was applied 
to each immunoadsorbent  column and incubated for 1 h at 4°C. The effluent equivalent to the 
void volume of the column was collected and the column was washed with a volume of cold 
phosphate-buffered saline (PBS)  that  was  10  times the  column bed  volume. The column- 
adsorbed material was then eluted with 3 ml of 0.175  M  glycine-HC1 buffer, pH  3.2.  The 
eluates were  neutralized immediately with  0.5  M  potassium phosphate  buffer, pH  8,  and 
dialyzed against PBS at 4°C. 
Assay for Augmenting Activity.  The activity of TaF in untreated cell-free extracts of FL10 or 
immunoadsorbent fractions of those extracts were assayed by their addition to in vitro cultures 
of spleen cells from mice primed 4-6 wk previously with 100/~g DNP-KLH and 109 PV. Spleen 
cells were cultured in a  modified Mishell-Dutton system (22) in 24-well flat-bottomed dishes 
with a cell concentration of 4 ×  106/ml of culture media and maintained in a humidified 5% 
CO2/95% air atmosphere at  37°C. To assay TaF activity, the cell-free  extract of FL10 was 
added to cultures on day 0. Because preliminary experiments showed the effective  dose range 
to be rather narrow, two doses of the FL10 cell extract, equivalent to 5 X 104 or 105 cells, were 
used. After 5 d, the numbers of anti-DNP IgG plaque-forming cells (PFC) were quantitated in 
a modified hemolytic plaque assay (23) by subtracting the number of direct (IgM) PFC from 
the total number ofTNP-specific PFC that were developed with a polyvalent rabbit anti-mouse 
immunoglobulin  antiserum. Target sheep erythrocytes were coupled with trinitrophenyl (TNP) 
according to the method of Rittenberg and Pratt (24). 
Data Analysis.  From the results of 3-4 individual wells, the mean and standard deviation of 
PFC  for  each  group were calculated. Results of in vitro antibody-forming cell assays  were 
statistically analyzed with a two-tailed Student's t test. 
Results 
Staining of an Augmenting T  Cell Hybridoma with Monoclonal Antibodies against an Igh-1- 
Linked  T Cell Alloantigen.  All strains of mice possessing the allotypes Igh-1  d and Igh- 
1  e were shown previously to express a  determinant recognized by conventional anti- 
Tsu  a antiserum (15). This conventional  antiserum has at least two different specificities 
and monoclonal antibodies against each of these two alloantigens have been estab- 
lished (16,  18).  Therefore, experiments were performed to determine whether or not 
the augmenting T  cell hybridoma FL 10, derived from A/J mice, expressed an antigen 
recognized  by  conventional anti-Tsu  d  antiserum  and/or  one  of  the  monoclonal 
antibodies specific for T  cell alloantigens linked to the Igh-1  d'e loci. The reactivity of NAKAJIMA ET AL.  21 13 
these reagents with FL10 and, as a control, the T  suppressor hybridoma 7C3-13 that 
originated from BI0.BR mice, was assessed by indirect immunofluorescent staining. 
The results of one representative typing experiment are presented in Table I. Only 
FLI0 was  positively stained  by both conventional  anti-Tsu  a antiserum  and  mono- 
clonal anti-Tind  a. With higher dilutions of either reagent, the number of positively 
stained  FLI0 ceils was greatly reduced  (data not shown).  Positive staining of FL10 
with monoclonal anti-Tsu  d or anti-Tthy  d was not detected. Neither conventional anti- 
Tsu  a antiserum, nor any of the monoclonal antibodies reacted with 7C3-13. 
Adsorption of Hybridoma-derived TaF by Immunoadsorbents Coupled with Anti-Ig  T-C Region 
Antibodies and Monoclonal Anti-I-A Antibodies.  Material extracted from FLI0 was shown 
previously to enhance  the secondary anti-DNP  antibody response to DNP-KLH in 
the  presence  of KLH-primed helper T  cells  (12).  Thus,  experiments were  done  to 
determine whether cell-free, KLH-specific TaF  from FL10 bears determinants  rec- 
ognized  by  monoelonal  anti-Tind  a  antibody.  In  addition,  since  TaF  produced  by 
FL10  was  already  shown  to  be  adsorbed  by conventional  anti-Ia  antiserum  (12), 
adsorption of the TaF activity with a monoclonal anti-I-A antibody was tested. This 
monoclonal  antibody,  designated  14P,  was  previously reported  to  be specific for a 
unique membrane determinant that is expressed by FL10 and controlled by the I-A  k 
subregion, as determined by adsorption studies (19). 
Columns were prepared using Sepharose conjugated with conventional antisera or 
the y-globulin fraction of ascites from hybridoma-bearing mice and used as immu- 
noadsorbents.  Because both monoclonal anti-Tind  a and anti-Tsu a antibodies  are of 
the IgG1 subclass, Sepharose coupled with the myeloma protein MOPC-31  served as 
a negative control. Cell-free material extracted from FL10 was applied to the various 
immunoadsorbents, and, after incubation, the filtrate and acid eluates were collected. 
The augmenting activity of these column preparations was assessed by their addition 
to cultures of DNP-KLH-primed spleen cells from A/J and C3H mice. The results of 
these experiments are shown in Fig.  1.  Even in the absence of TaF, the response of 
A/J  spleen  cells was extremely high.  Although  there was a  large difference in  the 
magnitude  of the  response  between  the  two  strains,  untreated  extract  from FL10 
significantly  enhanced  the  number of IgG anti-DNP  plaque-forming cells  in  both 
TABLE  I 
Expression of the Igh-la'e-Linked  AUoantigen, Tind  a on the Cell Hybridoma, FL  I O* 
Reagent  Dilution 
Percent  of cells positively 
stained 
FL10  7C3-13 
Conventional anti-Tsu  d*  1:20  30  3 
Monoclonal anti-Tsu  a§  1 : 10  <1  <1 
Monoclonal anti-Tind  a§  1 : 10  57  <1 
Monoclonal anti-Tthy  a§  1:10  <  1  <  1 
NMS +!  1:10  <1  <1 
* T  cell hybridomas were incubated with whole mouse serum or ascites and then indirectly 
stained with fluoresceinated goat anti-mouse Ig.  Positively stained cells determined with 
fluorescence microscope. 
* Whole serum. 
§ Ascites from hybridoma-bearing mice. 
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FIG.  I.  Antigen-specific  TaF from FL10 bears both Tind  d and I-A  k region-encoded determinants. 
4  ×  l0  e  DNP-KLH  primed spleen ceils from  A/J and  C3H  mice were cultured for  5  d  in  the 
presence of 0.5 #g of DNP-KLH with or without the addition of FL10 cell extract containing TaF. 
Filtrates or acid eluates were prepared from antigen- or antibody-coupled Sepharose columns to 
which FL 10 cell extract was applied, as described in Materials and Methods. Column fractions were 
added to cultures on day 0. Bars represent the average number of IgG anti-DNP PFC from three to 
four culture wells and the standard deviation. 
A/J and C3H spleen cells cultures  (P <  0.005)  when compared with the response of 
control cultures without TaF. While TaF was not detected in filtrates from columns 
coupled with KLH, column eluates significantly increased the response of both A/J 
and C3H  (P <  0.005)  in confirmation of the antigen specificity of the FL10 factor. 
FL10 extract passed through immunoadsorbents prepared with monoclonal  14P was 
no longer able to enhance the anti-DNP antibody response. Acid eluates from the 14P 
column significantly enhanced the in vitro antibody response (P <  0.005), indicating 
the  recovery  of TaF.  The  augmenting  activity  was  also  removed  from  the  FL10 
extract after passage through  columns conjugated with conventional  anti-Tsu ° and 
monoclonal anti-Tind  d antibodies and the activity to increase antibody responses was 
fully recovered in the acid eluates of these columns (P <  0.005 when compared with 
control  responses).  In  contrast,  adsorption  of TaF  by monoclonal  anti-Tsu a  or by 
MOPC-31  columns was not observed and the filtrates from these columns contained 
the original enhancing activity. 
Reconstitution of TaF Activity by Combining Column Filtrates: the Antigen-binding Chain of 
Monoclonal  TaF  Bears the  Tind a  Determinant.  Experiments  were  done  to  elucidate 
further the basic composition of the monoclonal TaF derived  from FL10.  Previous 
studies of antigen-specific TsF extracted from T suppressor hybridomas indicated that 
the TsF is composed of two distinct chains of which one binds antigen and the other 
bears antigenic determinants of the I-J subregion (25).  Extract from suppressor cells 
contains  the  two chains,  both  in  associated and  nonassociated  forms, although  for 
effective suppression  both  chains  are  required.  Thus,  addition  of column  filtrates 
containing  either  chain  alone  to  spleen  cell  cultures  has  no  effect,  but  when  the NAKAJIMA ET AL.  21 15 
filtrates  are  simultaneously  added,  suppression  is  induced.  This  study  therefore 
examined  whether  the  Tind  d determinant  is  present  on  the  antigen-binding  chain 
rather  than  the  I-A-bearing chain.  Thus,  TaF  was  incubated  on columns coupled 
with KLH, monoclonal anti-I-A  k (14P) or monoclonal anti-Tind  d. Filtrates from each 
column, equivalent to the extract of 5 ×  10  4 or 10  5 FLI0 ceils, or an equal mixture of 
two column filtrates were added to cultures of A/J and C3H spleen ceils. In agreement 
with  our previous  findings, TaF  activity was removed from filtrates of KLH,  14P, 
and monoclonal anti-Tind  d, but not monoclonal anti-Tsu  d, columns (Fig. 2).  Recon- 
stitution of augmenting activity occurred when the filtrates of the  14P column were 
combined with that of the KLH or monoclonaI anti-Tind  d column, but not when the 
KLH and anti-Tind  d column filtrates were simultaneously added. Similar data were 
obtained  in  two other experiments using A/J  mice as the responding strain.  These 
results  indicate  that  monoclonal  TaF  is  a  molecular  complex  consisting  of  two 
components:  one chain  bears I-A subregion-controlled  determinants  and  the other 
chain  possesses  both  antigen-binding  activity  and  the  Tind  d  determinant.  FLI0- 
derived  cell  extract  contains  the  two  chains  in  both  associated  and  nonassociated 
forms. Similar to the findings for monoclonal TsF, both chains of the TaF must be 
present to induce an effect on the immune response. 
Genetic Restriction of Augmentation Induced by Monoclonal TaF.  The existence of both 
Igh-l-linked  and  I-A subregion-controlled  determinants  on  the  monoclonal  TaF 
derived  from FL10  raised  the following question.  Must  the responding spleen cells 
share  the  I  region  haplotype and/or  the  immunoglobulin  allotype with A/J  mice, 
from which FL10 was derived, for FL10-derived TaF to successfully induce augmen- 
tation  of the  response? The  results  presented  in  Fig.  1 already demonstrated  that 
monoclonal TaF from FL10 could equally enhance  the response of A/J,  the strain 
from which FL10 was derived, and C3H, which shares the I region, but not the Igh- 
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F~o.  2.  Reconstitution of TaF activity by combining column filtrates.  Spleen celt  cultures were 
performed as  in  Fig.  h  FL10  cell  extracts were applied  to  immunoadsorbent columns and  the 
filtrates were collected. Column filtrates equal to the extract of 5 X  104 FL10 cells or an equivalent 
mixture of filtrates from two columns were added  to in vitro cultures on day 0.  (*)  a  significant 
difference in the response compared with that of control cultures without TaF (P <  0.005). 2116  Tind  a  DETERMINANT ON THE  ANTIGEN-BINDING CHAIN OF  TaF 
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Fio.  3.  Genetic  restriction  of augmentauon  by  FL10-derived  TaF.  Spleen  cell  cultures  were 
performed as in Fig. 1 with or without the addition of FL10-derived TaF. (*) a significant difference 
in the response compared with that of control cultures without TaF (P <  0.005). 
1 locus with FL10.  To elucidate further the genetic restriction, the ability of mono- 
clonal TaF to augment the response of other strains of mice was tested. As shown in 
Fig.  3,  induction  of augmentation  by TaF  occurred  only  if the  responding  strain 
shared  the  I-A  k subregion  with  FL10.  Although  C.AL-20  mice express  the  Tind  d 
determinant, FL10-derived TaF did not induce augmentation of this strain's response, 
even when  several different  doses of TaF were tested  (data  not  shown).  Thus,  the 
effect of TaF is not dependent on identity with the Igh-1 locus of the responder. 
Discussion 
Originally, the T  cell marker, Tind  d, was described as an alloantigen preferentially 
expressed on a mature, peripheral T  cell population bearing the Lyt-1 differentiation 
marker  (15).  In  vivo  injection  of monoclonal  anti-Tind  d  antibody  induced  either 
enhancement  or  suppression  of the  response  to  sheep  erythrocytes,  but  the  exact 
biologic properties of the Tindd-positive T  cells were not further defined. Mapping of 
the Tind  d determinant with Igh recombinant strains of mice limited the gene to that 
region of chromosome 12 to which Tsu  d was assigned, between the end of the Igh-C 
cluster and a minor transplantation antigen, H(Ig) (15,  16). Because neither Tsu  d, nor 
Tind  d is  located  among the heavy chain  variable region  genes,  they are not  genes 
encoding variable region framework or idiotypic determinants. Thus, the map position 
on chromosome 12 suggested that these T  cell antigens were allotypic markers on the 
constant region of the T  cell receptor for antigen. 
Our study was initiated by the finding that conventional anti-Tsu  d, which contains 
both  anti-Tsu  d  and  anti-Tind  d  specificities,  and  monoclonal  anti-Tind  d  antibody 
could stain the T  cell hybridoma FL10. This Lyt-1+2  -  T  cell hybrid, originating from 
A/J  (Igh-1  e)  mice, was previously shown to produce TaF, which can bind to KLH 
and also enhance the antibody response to haptens coupled to KLH (12). In agreement 
with  membrane fluorescence,  our experiments found  that  TaF  derived  from FL10 
bears  the  Tind  d determinant.  This was clearly demonstrated  by the  fact  that  the 
augmenting  activity  of TaF  was  completely  adsorbed  by  columns  coupled  with NAKAJIMA ET AL.  2117 
conventional anti-Tsu  d, which contains both anti-Tind  d and anti-Tsu  d activities, or 
with  monoclonal  anti-Tind  d,  while  filtrates  from  monoclonal  anti-Tsu  d  columns 
retained the enhancing activity. In addition, TaF activity was bound to and eluted 
from  Sepharose  coupled with  monoclonal  anti-I-A  antibody  (14P)  or with  KLH. 
Thus, the presence of Tind  d and I-A  k subregion-controlled determinants on antigen- 
specific, monoclonal TaF were clearly shown. Additional results indicated that TaF 
was  composed of two chains  and  that  the Tind  d determinant  was  present  on  the 
KLH-binding chain, rather than the I-A  k- bearing chain of the monoclonal TaF. The 
14P column filtrate, although by itself devoid of activity, contained a component that 
could complement otherwise inactive filtrates from either KLH or monoclonal anti- 
Tind  d columns for the restoration of augmenting activity. In contrast, a  mixture of 
KLH  and  monoclonal anti-Tind  d column  filtrates failed to enhance the antibody 
response, suggesting that these column filtrates contained similar components of the 
monoclonal TaF.  These findings  indicate that  Tind  d is  a  marker on  the constant 
portion of the antigen-binding chain associated with TaF. Further support for this 
conclusion is now being provided by the gel electrophoretic studies of radiolabeled 
TaF with monoclonal anti-Tind  d and anti-I-A antibodies (S. Miyatani, K. Hiramatsu, 
P. Nakajima, F. L. Owen, and T. Tada, manuscript submitted for publication). 
According to the original report by Owen et al.  (14), Taniguchi and colleagues 
prepared similar conventional and monoclonal antibodies against Igh-lb-linked T cell 
alloantigens (26-29). They found that certain monoclonal reagents were specific either 
for  antigen-binding  chains  of suppressor  or  augmenting  factors,  indicating  that 
functionally diverse T  suppressor  and  T  augmenting  cells  utilize  different T  cell 
receptor isotypes (29). The relationship of the Igh-1 b T  cell alloantigens with respect 
to Tind  d and Tsu  d remains to be determined. 
All these data indicate that a  region of mouse chromosome 12 encodes at least a 
portion of the constant region genes that comprise the antigen-binding structure of T 
cells. The total number of peripheral T  cells recognized by these reagents, however, 
is rather small  (14,  15,  18). This suggests that other T  cell isotypes mapping to this 
region may be discovered. The mature T  cell isotypes defined thus far appear to be 
expressed by T  cell subsets that can bind antigen in the absence of MHC products 
(12, 20). Tests of a panel of monoclonal antibodies specific for Tthy  d, Tind  d, and Tsu  d 
found  that  none  reacted with  cytotoxic effector or  MLR-reactive T  ceils  (G.  M. 
Spurll, M. Frye, L. Riendeau, A. Finnegan and F. L. Owen, manuscript in prepara- 
tion). Furthermore, Tinda-positive and Tsua-positive cells are ontogenetically related 
in that Tthyd-positive thymocytes are precursors of both of these mature T  cell subsets 
(30). The antigen receptors used by this family of regulatory T  cells may be distinct 
from those used by the majority of T  cells, which see antigen in the context of H-2 
molecules. Only further attempts to produce monoclonal anti-IgT-C antibodies and 
the  generation  of probes  to  identify IgT-C  genes  at  the  DNA  level  will  provide 
answers. 
It is well documented that the biologic functions of conventional TsF and TaF are 
governed by genetic restrictions imposed by the I region (13, 31, 32), and I-J and I-A 
subregions,  respectively.  Our  findings  show  that  augmentation  of the  secondary 
response induced with FL10-derived TaF also occurred only if the responding cells 
shared the Iak region. Despite the presence of the Igh-1-1inked determinant, Tind  d, on 
TaF, the induction of augmentation did not occur if the responding ceils were only 2118  Tind d DETERMINANT ON THE ANTIGEN-BINDING CHAIN OF TaF 
Igh-1 compatible. 
The existence of different IgT-C region isotypes and their association with different 
I region-controlled products prompts speculation as to the role each molecule plays in 
the regulatory activity of T  cell factors. Both TaF and TsF activate a second type of 
cell, that is effective in regulatory circuits, either enhancing or suppressing the immune 
response  (12,  13,  31,  33).  Thus,  each  type of factor must  fulfill  at  least  two  basic 
functions: the selection of the secondary acceptor cell and the activation of that cell. 
Future questions to be addressed are: which function  (or functions)  is performed by 
the IgT-C isotypic determinants on the antigen-binding chain vs. that performed by 
the I region-controlled chain, and further, how are these functions accomplished? 
Summary 
Monoclonal  antibodies  specific  for  mouse  T  cell  alloantigens,  Tind  a  and  Tsu  a, 
linked to the Igh-1 locus on chromosome 12, were used to directly define the antigen- 
binding  molecule produced  by a  cloned  hybridoma.  The T  cell hybridoma,  FL10, 
was established from antigen-binding T  cells of A/J mice. FL10 produces an antigen- 
specific  augmenting  T  cell  factor  (TaF)  that  bears  a  unique  I  region-controlled 
determinant  (I-A) and has antigen-binding capacity. The Tind  a, but  not  the Tsu  a, 
determinant  was detected on the surface of FL10.  The presence of both Tind  a and 
I-A subregion-controlled  determinants  on  FL10-derived  TaF  was  directly  demon- 
strated by the adsorption of TaF with immunoadsorbents prepared with monoclonal 
antibodies. The Igh-l-linked T  cell alloantigen, Tsu  a, was not found on TaF. Further 
experiments indicated that Tind  a is present on the antigen-binding polypeptide chain 
and not on the second chain bearing the I-A determinant. Despite the presence of the 
Tind  a determinant  on hybridoma-derived TaF, augmentation  induced  by TaF was 
restricted by the H-2 type of the responding mice and not by the Igh-1 allotype. 
The excellent assistance of Ms. Yoko Yamaguchi in the preparation of this manuscript is greatly 
appreciated. 
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